AKT phosphorylation suppresses temozolomide-induced glioma cell senescence via its various downstream survival signals [25–27]. Combined treatment of the AKT inhibitor and temozolomide has additive effects on glioma and melanoma treatment [28,29]. Here, AKT1 is linked to melanoma.